Oncolytics Biotech, Inc. (ONCY)
0.631
-0.01
(-1.59%)
USD |
NASDAQ |
Oct 02, 16:00
0.6246
-0.01
(-1.01%)
After-Hours: 20:00
Oncolytics Biotech EPS Diluted (Quarterly) : -0.0788 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0788 |
| March 31, 2026 | -0.0823 |
| December 31, 2025 | -0.0139 |
| September 30, 2025 | -0.0975 |
| June 30, 2025 | -0.058 |
| March 31, 2025 | -0.0551 |
| December 31, 2024 | 0.0112 |
| September 30, 2024 | -0.0892 |
| June 30, 2024 | -0.0684 |
| March 31, 2024 | -0.0658 |
| December 31, 2023 | -0.0393 |
| September 30, 2023 | -0.106 |
| June 30, 2023 | -0.0859 |
| March 31, 2023 | -0.0763 |
| December 31, 2022 | -0.1059 |
| September 30, 2022 | -0.0578 |
| June 30, 2022 | -0.0692 |
| March 31, 2022 | -0.0946 |
| December 31, 2021 | -0.1117 |
| September 30, 2021 | -0.0704 |
| June 30, 2021 | -0.1086 |
| March 31, 2021 | -0.1023 |
| December 31, 2020 | -0.1623 |
| September 30, 2020 | -0.1214 |
| June 30, 2020 | -0.1244 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0311 |
| December 31, 2019 | -0.5403 |
| September 30, 2019 | -0.118 |
| June 30, 2019 | -0.1946 |
| March 31, 2019 | -0.2016 |
| December 31, 2018 | -0.2132 |
| September 30, 2018 | -0.1543 |
| June 30, 2018 | -0.2091 |
| March 31, 2018 | -0.2253 |
| December 31, 2017 | -0.2242 |
| September 30, 2017 | -0.1516 |
| June 30, 2017 | -0.212 |
| March 31, 2017 | -0.2153 |
| December 31, 2016 | -0.2848 |
| September 30, 2016 | -0.2185 |
| June 30, 2016 | -0.1474 |
| March 31, 2016 | -0.2075 |
| December 31, 2015 | -0.2134 |
| September 30, 2015 | -0.1452 |
| June 30, 2015 | -0.2318 |
| March 31, 2015 | -0.3062 |
| December 31, 2014 | -0.3346 |
| September 30, 2014 | -0.4364 |
| June 30, 2014 | -0.4355 |
| March 31, 2014 | -0.5167 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
| Vicapsys Life Sciences, Inc. | -0.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.442M |
| Total Expenses (Quarterly) | 9.442M |
| Enterprise Value | 74.98M |
| Earnings Yield | -43.19% |
| Normalized Earnings Yield | -43.25 |